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Abstract 
Brucellosis is a worldwide extended zoonosis caused by Brucella spp. 
These gram-negative bacteria are not readily detected by innate immunity, a 
virulence-related property largely linked to their surface lipopolysaccharide 
(LPS). The role of the LPS lipid A and O-polysaccharide in virulence is well 
known. Moreover, mutation of the glycosyltransferase gene wadC of B. abortus, 
although not affecting O-polysaccharide assembly onto the lipid-A core section 
causes a core oligosaccharide defect that increases recognition by innate 
immunity. Here, we report on a second gene (wadB) encoding a LPS core 
glycosyltransferase not involved in the assembly of the O-polysaccharide-linked 
core section. As compared to wild-type B. abortus, a wadB mutant was 
sensitive to bactericidal peptides and non-immune serum, and was attenuated 
in mice and dendritic cells. These observations show that as WadC, WadB is 
also involved in the assembly of a branch of Brucella LPS core and support the 
concept that this LPS section is a virulence-related structure. 
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1. Introduction 
The -2 Proteobacteria of the genus Brucella cause brucellosis, a disease 
that is considered one of the most common global zoonoses [1]. The genus 
includes several closely related species among which B. abortus preferentially 
infects cattle, B. suis swine and wildlife and B. melitensis goats and sheep, and 
in all these animals brucellosis is a major cause of abortions and infertility. 
Humans become infected via direct contact with affected livestock and through 
consumption of unpasteurized dairy products. Human brucellosis is a grave and 
debilitating disease that may lead to permanent sequelae, requires prolonged 
and combined antibiotherapy and is fatal in 1-5% of untreated cases [2].  
The brucellae behave as facultative intracellular parasites, and their 
virulence results from a complex and not fully elucidated set of mechanisms that 
include the ability to escape prompt detection by innate immunity during the 
initial stages of infection [3]. Studies carried out mostly with B. abortus have 
shown that the outer membrane lipopolysaccharide (LPS) [1,3] lipoproteins [3] 
and ornithine lipids [4] induce a low proinflammatory response indicative of the 
absence of the marked pathogen-associated molecular patterns that are 
detected by innate immunity. These outer membrane components structurally 
depart from counterparts molecules in most gram-negative bacteria, and the 
differences are particularly accentuated in the LPS. In B. abortus, B. melitensis 
and B. suis, LPS is of the smooth (S) type and is thus made of an O-
polysaccharide bridged to lipid A by an intermediate core oligosaccharide. 
Although it has been known for decades that Brucella lipid A and O-
polysaccharide are involved in virulence [5], the role of the core oligosaccharide 
has only been uncovered recently. We identified a core glycosyltransferase 
gene (wadC) whose disruption increases recognition of the LPS by 
complement, bactericidal peptides and the receptor complex MD2-TLR4, which 
leads to an increase in the proinflammatory response and the subsequent 
attenuation of the mutated bacteria [6]. Mutants in wadC remain S (i.e. they 
carry the O-polysaccharide), which is in contrast with the lack of a S-LPS of 
mutants in wadA, the only other glycosyltransferase known to be involved in the 
synthesis of the Brucella LPS core [7]. On these bases, we proposed that the B. 
abortus LPS core has a branched structure [6] and this was confirmed in a more 
recent structural study [8]. Here, we report that wadB, a hitherto unidentified 
LPS gene, encodes a glycosyltransferase involved in the synthesis of the LPS 
core branch, and show that its disruption also leads to attenuation.  
 
2. Experimental procedures  
2.1 Bacterial strains and growth conditions.  
The bacterial strains and plasmids used in this study are listed in Table 1.  
Bacteria were routinely grown in standard tryptic soy broth (TSB; Biomerieux; 
http://www.biomerieux.com) or agar (TSA; Conda-Pronadisa; 
http://www.condalab.com/es) either plain or supplemented with kanamycin (Km) 
at 50 μg/mL, chloramphenicol (Cm) at 20 μg/mL, nalidixic acid (Nal) at 25 μ
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g/mL, and/or 5% sucrose. All strains were stored in skim milk (Scharlau) at - 80°
C.  
 
2.2 DNA manipulations.  
Plasmid and chromosomal DNA were extracted with Qiaprep spin Miniprep 
(Qiagen GmbH, Hilden, Germany) and Ultraclean Microbial DNA Isolation Kit 
(Mo Bio Laboratories) respectively. When needed, DNA was purified from 
agarose gels using a Qiaquick Gel extraction kit (Qiagen). DNA sequencing 
was performed by “Servicio de Secuenciación del CIMA” (“Centro de 
Investigación Médica Aplicada”, Pamplona, Spain). Primers were synthesized 
by Sigma-Genosys Ltd. (Haverhill, United Kingdom). Searches for DNA and 
protein homologies were carried out using the NCBI (National Center for 
Biotechnology Information; http://www. ncbi.nlm.nih.gov) and the KEGG 
database (http://www.genome.jp/kegg/) servers.  Analysis of 
glycosyltransferases families and domains was performed using CAZy 
database (www.cazy.org). 
An in-frame deletion mutant in BAB1_0351 (henceforth BaΔwadB) was 
constructed by PCR overlap using genomic DNA of B. abortus 2308 (Ba-
parental) as DNA template. Primers were designed based on the sequence of 
B. abortus 2308 (http://www.ncbi.nlm.nih.gov/). First, two PCR fragments were 
generated: oligonucleotides wadB-F1 (5´-GCATGATTACCCCGCTGAT-3´) and 
wadB-R2 (5´-CGCAATCTCGTCTTTGTTGAG-3´) were used to amplify a 296 
bp fragment including codons 1 to 48 of BAB1_0351 as well as 152 bp 
upstream of the BAB1_0351 start codon; and oligonucleotides wadB-F3 (5´-
CTCAACAAAGACGAGATTGCGGGTGGCGTGAAGGAAATCT-3´) and wadB-
R4 (5´- TGATAGCCGAGCCTCTTCAG-3´) were used to amplify a 274 bp 
fragment including codons 196 to 239 of the ORF and 139 bp downstream of 
the stop codon. Both fragments were ligated by overlapping PCR using 
oligonucleotides wadB-F1 and wadB-R4 for amplification and the 
complementary regions between wadB-R2 and wadB-F3 for overlapping. The 
resulting fragment, containing the BAB1_0351 deletion allele, was cloned into 
pCR2.1 (Invitrogen), to generate plasmid pYRI-1, sequenced to ensure the 
maintenance of the reading frame, and subsequently subcloned into the BamHI 
and the XbaI sites of the suicide plasmid pJQKm (Table 1). The resulting 
mutator plasmid (pYRI-2) was introduced in Ba-parental by conjugation. The 
first recombination (integration of the suicide vector in the chromosome) was 
selected by Nal and Km resistance, and the second one (excision of the mutator 
plasmid producing   the mutant by allelic exchange) by Nal and sucrose 
resistance and Km sensitivity. The resulting colonies were screened by PCR 
with primers wadB-F1 and wadB-R4, which amplify a fragment of 570 bp in the 
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mutant and a fragment of 1011 bp in Ba-parental. The mutation resulted in the 
loss of 60% of the ORF (88% of the glycosyltransferase domain). 
For complementation, a plasmid harboring ORF BAB1_0351 (pwadB) was 
constructed as described previously [9] using genomic DNA of B. abortus 2308 
as the DNA template. Briefly, PCR-amplified ORF BAB1_0351 was inserted into 
the Gateway-compatible vector pDONR221 by site-specific recombination 
(pYRI-3). The product was then introduced into One Shot® OmniMAX™ 2-T1R 
Chemically Competent E. coli cells and the bacterial transformants were 
selected on TSA-Km. The clone carrying B. abortus BAB1_0351 was extracted, 
and the DNA containing this ORF was subcloned in pRH001 [10] to produce 
plasmid pwadB. To complement the wadB mutation, plasmid pwadB was 
introduced into BaΔwadB by mating with E. coli S17-1λpir and the conjugates 
harboring pwadB were selected by plating onto TSA-Nal-Cm plates, which were 
incubated at 37°C for 3 days. 
For detection of bacteria in the cell infection experiments (see below), 
plasmid pBBR1MCS-2 GFP was introduced by conjugation in the different 
Brucella strains (Table 1).  
 
2.3 Sensitivity to brucellaphages, dyes, antibiotics and polymyxin.  
The sensitivity to the S (Tb, Wb, Iz) and R (R/C) specific brucellaphages 
was measured as described previously [11]. The minimal inhibitory 
concentration (MIC) of fuchsin, thionin and safranin (dyes used in Brucella 
biovar typing) was determined in Müller-Hinton broth by standard procedures. 
For polymyxin B, exponentially growing bacteria were adjusted to an optical 
density equivalent to 1 of the McFarland scale. The MIC was determined by the 
E-test method (AB Biomérieux, Solna, Sweden) on Müller-Hinton agar.  
2.4 Sensitivity to non-immune serum.  
Exponentially growing bacteria were adjusted to 104 colony forming unit 
(CFU/mL) in phosphate buffered saline (PBS) and dispensed in triplicate in 
microtiter plates (45 μL/well) containing fresh normal bovine serum (90 μL/well). 
After 90 min of incubation at 37 °C, 200 μL of brain heart infusion broth was 
dispensed into each well, the bacterial suspension mixed, and 100 μL aliquots 
plated on TSA. The Ba::Tn5-per (R-LPS) and Ba::Tn5-bvrR (S-LPS) mutants 
were used as controls. The results were expressed as the percentage of 
survival with respect to the CFU in the inocula. 
2.5 LPS extraction and characterization.  
S-LPS was obtained by methanol precipitation of the phenol phase of a 
phenol-water extract, followed by digestion with nucleases (10 mg S-LPS/mL in 
175 mM NaCl, 0.05% NaN3, 0.1M Tris-HCl [pH 7.0]; 50 μg/mL each of DNase-II 
type V, and RNase [Sigma, St. Louis, Missouri, U.S.A.] 30 min at 37°C) and 
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proteinase K (three cycles; 50 μg/mL, 3 h at 55°C). LPS was then sedimented 
by ultracentrifugation, extracted four times with chloroform-methanol (2:1 
[vol/vol]) to remove free lipids, and freeze-dried [12]. Alternatively, LPS was 
extracted from whole bacteria by the sodium dodecylsulfate (SDS) -proteinase 
K protocol [13]. LPS were electrophoresed in 7 cm 18% polyacrylamide (PAGE) 
gels in SDS Tris-HCl-glycine [1,14]. Alternatively, LPS were analyzed in 16 cm 
18% PAGE gels in Tris-Tricine-HCl-glycine (TSDS-PAGE) [2,15]. For Western 
blots, gels were electro transferred onto nitrocellulose sheets (Whatman, 
Dassel, Germany), blocked with 3% skim milk in PBS with 0.05% Tween 20 
(PBST) overnight, and washed with the same buffer. Monoclonal antibodies 
A68/03F03/D05, A68/24D08/G09 and A68/24G12/A08 (all of which recognize 
R-LPS epitopes [3,16]) were diluted in PBST and blots were developed with 
peroxidase-conjugated goat anti-mouse immunoglobulin (Nordic immunological 
laboratories, Tilburg, Netherlands) or peroxidase labeled protein G and 4-
chloro-1-naphtol-H2O2.  
2.6 Polycationic peptide-LPS interactions.  
The affinity of Ba-parental and BaΔwadB LPS for polycationic peptides was 
measured using peptide 19.8-4 (derived from the Limulus anti-LPS factor) 
[1,3,17] in comparison with the LPS of the B. abortus wadC mutant (BaΔwadC) 
described previously [3,6], and E. coli ATCC 35218. For this purpose, ELISA 
plates were coated with the peptide (10 µg/mL in 20 mM in PBS; 100 µl/well) at 
4ºC overnight and washed extensively with PBS-Tween 20. Then, the 
appropriate LPS was dispensed (10 µg/mL in PBS; 100 µl/well) and plates 
incubated at 37ºC for 1 h. Free peptide was detected with biotinylated E. coli 
LPS (100 µl/well of 1 µg/mL in PBS for 30 min at 37 ºC) and a horseradish 
peroxidase-conjugated Streptavidin (100 μL; 1/2000 in PBS at room 
temperature for 30 min) - 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic 
acid)/H2O2 system. Binding was expressed as the ratio [(LPStested –LPS0) x 100]/ 
(LPSEc – LPS0) where LPStested is the value obtained with the LPS of each B. 
abortus strain, LPSEc is the value obtained with E. coli LPS, and LPS0 the 
values obtained for the biotinylated E. coli LPS and no buffer and no LPS in the 
binding steps. 
2.7 Intracellular replication. 
 Bone marrow cells were isolated from femurs of 7-8-week-old C57BL/6 
female mice and differentiated into bone marrow-derived dendritic cells 
(BMDCs) as described previously [4,9,18,19]. Infections were performed by 
centrifuging bacteria carrying the plasmid pBBR1-MCS-2 GFP onto BMDCs 
(400 x g for 10 min at 4ºC; multiplicity of infection of 40) followed by incubation 
at 37°C for 30 min under a 5% CO2 atmosphere. The virB10 GFP mutant was 
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used as an avirulent control. BMDCs were washed extensively to remove 
extracellular bacteria and incubated in complete medium supplemented with 50 
g/mL gentamicin for 1 h to kill extracellular bacteria. Thereafter, the antibiotic 
concentration was decreased to 10 g/mL.  
To determine the number of intracellular bacteria per cell, BMDCs were 
grown on glass coverslips and inoculated with bacteria as described above. At 2 
and 48 h post-inoculation, coverslips were fixed with 3% paraformaldehyde, pH 
7.4, at 37°C for 15 min and washed three times with PBS. Coverslips were 
processed for immunofluorescence staining as previously described [5,20]. 
BMDCs were labeled using an antibody (rabbit anti mouse Rivoli) against a 
conserved cytoplasmic domain of MHC-II I-A-β subunits [6,21], followed by the 
secondary antibody donkey anti-rabbit Cy5. Bacteria were visualized directly 
since they expressed the green fluorescence protein encoded by the 
pBBR1MCS-2 GFP plasmid.  For each bacterial infection, a minimum of one 
hundred cells was analyzed under a Zeiss Axioplan 2 Fluorescence 
Microscope. The number of cells containing more than 10 bacteria/cell was 
recorded and expressed as a percentage with respect to the number of total 
infected cells. These experiments were done at least three times. 
2.8 Virulence assay in mice. 
One week before the start of the experiment, 7 week-old female BALB/c 
mice (Charles River, Elbeuf, France) were accommodated in cages with water 
and food ad libitum under biosafety containment conditions in the animal 
building of CITA of Aragón government (ID registration number ES-
502970012005). The animal handling and experimental procedures were 
performed in accordance with the current Spanish and European legislation (RD 
53/2013; Directive 14 86/609/EEC, respectively), and were supervised by the 
Animal Welfare Committee of the Institution (Protocol number R109/2009). 
Groups of 25 mice each were inoculated intraperitoneally with 5 x 104 CFU of 
BaΔwadB, BaΔwadC or Ba-parental, and the number of CFU in spleens was 
determined at 2, 4, 8, 12 and 24 weeks post-inoculation, as described 
previously [6,7]. An additional group of 10 mice were infected with the BaΔ
wadB-pwadB complemented strain, and analyzed at 8 and 12 weeks post-
infection. The identity of the spleen isolates was confirmed by PCR at each 
point-time and the individual data (CFU/spleen) were normalized by logarithmic 
transformation and expressed as the mean and standard deviation (n=5) of 
log10 CFU/spleen. Statistical comparisons of means were performed by a one-
way ANOVA test followed by the Fisher’s Protected Least Significant 
Differences (PLSD) test. 
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3. Results 
3.1 Identification of wadB, a glycosyltransferase gene involved in the 
synthesis of the LPS core section not linked to the O-polysaccharide. 
 To identify Brucella core glycosyltransferase candidates, we first searched 
the KEGG database (http://www.genome.jp/kegg/) for glycosyltransferases in 
Brucella spp., ruling out those previously assigned to the O-polysaccharide. 
Then, we looked for orthologous of these ORFs in Ochrobactrum anthropi 
(ATCC 49188), a close phylogenetic relative of Brucella that has a core 
structure close to that of B. abortus [6,8,22]. In addition to the Kdo transferase 
(BAB2_0209, kdtA or waaA), which is highly conserved in gram-negative 
bacteria and thus of less interest, we found B. abortus BAB1_1522 and O. 
anthropi Oant_1661 to be the closest (85.6%) homologues, followed by 
BAB1_0351 and Oant_0415 (62.0% homology) and BAB1_0639  and 
Oant_0608 (38.9%). Other matches showed less than 35% homology, the 
threshold below which protein sequence alignment becomes meaningless 
[8,23]. Of these three ORFs, B. abortus BAB1_1522 encodes WadC and B. 
abortus BAB1_0639 encodes WadA, the only two core glycosyltransferases 
described previously [7,9,24]. Their identification supported the appropriateness 
of the screening method and, accordingly, the remaining ORF (BAB1_0351) 
was a strong candidate for an additional core glycosyltransferase. Consistent 
with this possibility, the BAB1_0351 predicted protein contained the cI01298, 
cd06532 and PFAM01755 domains of glycosyltransferase family 25, which 
includes Brucella WadA as well as LPS glycosyltransferases of other bacteria. 
Following the accepted nomenclature for LPS genes [10,25], we provisionally 
named this gene wadB. 
To investigate whether BAB1_0351 was in fact involved in LPS synthesis, 
we constructed a non-polar mutant by in frame deletion of the sequence coding 
for amino acids 49 to 195, which eliminated the three consensus domains of 
glycosyltransferase family 25. The non-polar mutant (BaΔwadB) did not differ 
from the parental strain (Ba-parental) in growth rate, sensitivity to fuchsin, 
thionin and safranin. Moreover, the parental and the mutant strains showed 
similar sensitivity and resistance, respectively, to S and R brucellaphages [11], 
and an anti-S-LPS serum agglutinated both strains similarly. We then extracted 
the LPS from BaΔwadB, the pwadB-complemented and the parental strain, and 
compared the profiles in standard Tris-glycine SDS-PAGE (Figure 1A). The 
analysis showed that the high molecular weight S-LPS fraction of both BaΔ
wadB and Ba-parental had a similar profile. On the other hand, the R (low 
molecular weight) LPS fraction showed an increased mobility suggestive of a 
core defect (Figure 1A), and complementation with plasmid pwadB restored the 
parental mobility profile (Figure 1A). When we probed the BaΔwadB LPS with 
antibodies specific for the core of Brucella LPS, Moab A68/24G12/A08 (Figure 
1B), A68/24D08/G09 and A68/3F03/D05 (not shown) failed to react with either 
the high (S) or low molecular weight (R) fractions of the LPS of BaΔwadB, and 
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complementation with plasmid pwadB restored the reactivity. We finally 
compared the LPS of BaΔwadB and BaΔwadC by Tris-tricine-HCl-glycine SDS-
PAGE, a high-resolution method that showed a higher molecular weight for R-
LPS fraction of the former (Figure 1C). Since these results demonstrate that it 
encodes a core glycosyltransferase, they confirm the appropriateness of the 
wadB designation. Moreover, they show that WadB is not related to the section 
linked to the O-polysaccharide, and suggest that the LPS core defect in BaΔ
wadB is less severe than that in BaΔwadC.  
3.2 Deletion of wadB decreases the resistance to the bactericidal 
action of polycationic peptides and normal serum.  
B. abortus is characteristically resistant to killing by non immune serum and 
polycationic bactericidal peptides, two properties linked to the LPS structure. 
Thus, we first probed the mutants with polymyxin B. The MICs we found were 
1.5 µg/mL for Ba-parental, 0.75 µg/mL for BaΔwadC, 0.30 µg/mL for BaΔwadB 
and 1.5 µg/mL for the pwadB-complemented Ba∆wadB strain. To confirm that 
the defective core LPS is responsible for the increased sensitivity of the wadB 
mutant to polycationic peptides, we also probed the binding of purified LPS to 
the potent Limulus anti-LPS peptide 19.8-4 [12,17]. We found that the LPS of 
BaΔwadB and BaΔwadC bound more peptide than the LPS of Ba-parental 
(Figure 2, left panel). Binding of peptide 19.8-4 was much less intense for any 
B. abortus LPS than for E. coli LPS indicating than the core accounts only in 
part for the LPS-mediated resistance of B. abortus to polycationic peptides. This 
is in accordance with previous works that showed that, in contrast to 
enterobacterial lipid A, polymyxin B failed to bind B. abortus lipid A [13,26].  
Concerning the resistance to the killing action of normal serum, we 
observed that BaΔwadB and BaΔwadC were more sensitive than Ba-parental 
and that the core defect was less deleterious than the upset OM present in a 
mutant in the master regulator BvrR-S [27,28] (Figure 2, right panel). 
Interestingly, BaΔwadB, BaΔwadC and a Ba::Tn5-per mutant lacking the O-
polysaccharide but carrying an intact core (see Table 1 for reference) showed 
similar serum sensitivity (Figure 2, right panel). These results demonstrate that 
an intact core is as important as the O-polysaccharide in protecting S B. abortus 
against killing by bactericidal systems in normal serum. 
3.3 Deletion of wadB causes attenuation in dendritic cells and mice.  
B. abortus is characteristically able to multiply in dendritic cells [29]. To 
study the behavior of BaΔwadB in these cells, we infected C57BL/6 BMDC with 
BaΔwadB, BaΔwadC and Ba-parental, and scored the number of intracellular 
bacteria in infected MHCII positive cells at 2 and 48 h post-infection. As a 
control, we used a virB10 mutant (Table 1) defective in the Type IV secretion 
system required for normal intracellular trafficking and multiplication. As 
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expected [20, 29] , and regardless of  the strain, the vast majority of infected 
BMDCs contained less than 10 bacteria at 2 h post-infection (Figure 3A). At 48 
h post-infection, the proportion of BMDCs containing more than 10 bacteria 
increased for Ba-parental but not for the virB10 GFP mutant, as expected from 
their respective virulent and attenuated phenotype [6]. Both BaΔwadC and BaΔ
wadB displayed an intermediate phenotype (Figure 3A), as described before for 
the former mutant [6].  
We finally tested BaΔwadB in mice in comparison with BaΔwadC and Ba-
parental. Both BaΔwadB and BaΔwadC were attenuated (Figure 3B). Although 
the differences were not marked, the evolution of the CFU/spleen suggested a 
less attenuated profile for BaΔwadB, with higher CFU/spleen at weeks 8 and 24 
(p<0,05) (Figure 3B). In an independent experiment, the CFU/spleen obtained 
for the BaΔwadB -pwadB complemented control were similar to those of Ba-
parental strains at the post-infection time tested (8 weeks; mean and standard 
deviation of log CFU 6.14 ±0.39 and 6.63±0.50 respectively; p = 0.442).  
4. Discussion 
The results of this work extend those of a previous study in which we 
showed that a B. abortus mutant in wadC displayed an altered LPS core despite 
carrying the O-polysaccharide [6]. Kubler-Kielb and Vinogradov [8] have shown 
that, whereas the B. abortus, B. melitensis and B. suis N-formyl-perosamine O-
polysaccharide is linked to a few sugars stemming from the distal 3-deoxy-D-
manno-octulosonic-acid residue (Kdo2) of the core, the lipid A-linked Kdo1 is 
bound through mannose to four glucosamine units. Fully consistent with the 
identification of wadB and the characteristics of the BaΔwadB mutant, synthesis 
of this oligosaccharide should require more than one glycosyltransferase. 
Based on the arrangement of sugars in this oligosaccharide, the electrophoretic 
profiles reported here, and the annotation of wadC as a mannosyltransferase 
gene, it can be hypothesized that WadC transfers mannose to Kdo1 and that 
WadB takes part in a later step. Indeed, although the genomic comparisons do 
not clarify its substrate specificity, it can also be hypothesized that WadB acts 
as a glucosamine transferase (Figure 4). Consistent with the description of the 
core branch in the above-mentioned S Brucella species [8], orthologues of 
wadB and wadC are present in all these bacteria and their disruption does not 
alter their S phenotype (Mancilla, M., Conde-Álvarez, R., Moriyón, I, and M. 
Iriarte; unpublished results). 
Based on the observation that the core defect in BaΔwadC generates 
attenuation and that the mutated LPS is more readily recognized by elements of 
innate immunity, we have proposed that the Brucella LPS core branch is a 
virulence-related structure accounting in part for the stealthy behavior of these 
bacteria [3,6]. Since mutation of another glycosyltransferase involved in the 
synthesis of the same structure also causes attenuation, our hypothesis is 
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confirmed in the present work. As reported before (and confirmed here) for 
wadC, the disruption of the core caused by mutation of wadB diminished the 
resistance to bactericidal peptides and non-immune serum, increased peptide 
binding to LPS, and generated strains that were attenuated in dendritic cells 
and mice. It has to be noted that, although showing an overall similarity, the 
phenotypes of the BaΔwadB and BaΔwadC mutants were not identical. In vitro, 
we noted differences in polymyxin B sensitivity, a polycationic lipopeptide that 
targets the lipid A phosphates and anionic sugars in the inner core (the Kdo 
residues in the case of Brucella). Indeed, disruption of the Kdo1 glucosamine 
branch easily explains the decreased resistance of both mutants. However, the 
decrease did not parallel the extent of core damage observed in the 
electropherograms, and thus other factors may be relevant. They could relate to 
topological changes in other outer membrane components, to the three 
dimensional arrangement of the remaining core, or to both. On the other hand, 
the experiments in mice suggested a less attenuated phenotype for wadB than 
for wadC that would be consistent with a less severe damage of the LPS core. 
A putative model of LPS structure based on the studies of Kubler-Kielb 
and Vinogradov (8) and our results studying the role of wadC and wadB is 
presented in Figure 4. Obviously, a definite interpretation of these results 
requires structural elucidation of the core structure remaining in the wadB and 
wadC mutants or/ and in a wadB-wadC double mutant.  
We have proposed before that disruption of the structure of the Brucella 
LPS core can be exploited to develop vaccines that would elicit the early innate 
immunity recognition that leads to Th1 protective responses [24]. Although 
vaccine S19 has been successfully used in developed countries for the control 
and eradication of cattle brucellosis, the protection achieved is not optimal [30] 
and success using this vaccine requires a very proficient veterinary 
infrastructure. Previous experiments in the mouse model suggest that the B. 
abortus wadC core mutations could be either introduced in S19 to reduce its 
residual virulence but bolstering its immunogenic properties or in a wild-type 
background, in combination with other appropriate mutations, to develop 
improved vaccines [24]. In this context, the identification of wadB adds another 
target for the development of new generation anti-Brucella vaccines less 
pathogenic and more immunogenic than currently available vaccines A study of 
the vaccine properties of wadB and wadC mutants in various Brucella 
backgrounds is in progress.  
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FIGURE LEGENDS 
 
 
 
Figure 1. Mutant Ba wadB has a defect in the LPS core. (A) SDS-PAGE 
analysis of phenol-water LPS; and (B) Western blot analysis of phenol-water 
LPS with anti-LPS-core Moab A68/24G12/A08; and (C) TSDS-PAGE analysis 
of SDS-proteinase K LPS. 
 
Figure 2. Mutant Ba wadB shows increase sensitivity to polycationic 
peptides and normal serum. Left panel, LPS binding to the anti-LPS Limulus 
peptide 19.8.4. The graphic represents the results of one representative 
experiment. Right panel, bacterial survival after exposure to normal bovine 
serum for 90 min (bars are the mean ± standard error). 
 
      Figure 3. Mutant Ba wadB is attenuated in dendritic cells and mice. (A) 
Multiplication in BMDC (mean ± standard deviation of bacterial numbers in at 
least 100 BMDC); (B) infection kinetics in spleen in BALB/c mice (each point 
represents the mean ± standard deviation [n=5] of the logarithm of CFU). 
 
       Figure 4. Schematic representation of Brucella LPS according to the 
work of Kubler-Kielb (8). The putative sugars transferred by wadC and 
wadB are indicated. Kdo (3-deoxy-d-manno-octulosonic acid); Glc 
(glucose); Man (mannose); GlcN (glucosamine); Quin (quinovosamine) 
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Table 1. Bacterial strains and Plasmids 
Strain or 
plasmid 
Relevant characteristics Reference/Source 
Brucella    
Ba-parental 
 
Nal
R
 spontaneous mutant of the reference strain B. abortus 
2308 
[31]  
Ba wadB Ba-parental with a wadB 49-195 deletion 
 This work 
Ba wadB-
pwadB 
Ba wadB harboring plasmid pwadB This work 
Ba wadC Ba-parental  LPS core mutant [6] 
Ba::Tn5-per Ba-parental harboring the Tn5 inserted in per Mutant 9.49 in ref [32] 
Ba::Tn5-bvrR Ba-parental harboring Tn5 inserted in bvrR 
 
Mutant 65.21 in ref [27]  
 
virB10 GFP virB mutant harboring pBBR1MCS-2 GFP Km
R
 [20]  
Ba-parental 
GFP 
Ba-parental harboring pBBR1MCS-2 GFP Km
R
 [6] 
Ba wadB GFP Ba wadB harboring pBBR1MCS-2 GFP Km
R
 This work 
Ba wadC GFP Ba wadC harboring pBBR1MCS-2 GFP Km
R
 [6] 
 
E. coli 
  
S17-1 pir Mating strain with plasmid RP4 inserted into the chromosome. [33] 
Top10F´ F´{lacIq, Tn10(TetR)} 
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara leu) 7697 galU galK rpsL (StrR) endA1 nupG 
 
Invitrogen 
One shot 
OMNIMAX  
F´ {proAB lacI
q
 lacZΔM15 Tn10(Tet
R
 ) Δ(ccdAB)} mcrA Δ(mrr 
hsdRMS-mcrBC) Φ 80(lacZ)ΔM15 Δ(lacZYA-argF)U169 endA1 
recA1 supE44 thi-1 gyrA96 relA1 tonA panD 
Invitrogen 
 
Plasmids 
  
pCR2.1 Cloning vector Invitrogen 
pJQKm Derivative of pJQ200KS +; Km
R
  [34] 
 
pDONR221 Cloning vector containing attP recombination sites for BP 
reaction (Gateway system) 
 
Invitrogen 
pRH001 Derivative of pMR10 Km
R
; Cm
R
 [10]  
pYRI-1 570-bp of Ba-parental chromosomal DNA containing the wadB 
deletion allele, generated by PCR and cloned into pCR2.1 
 
This work 
pYRI-2 BamHI-XbaI fragment from pYRI-1 cloned into the 
corresponding sites of pJQKm 
 
This work 
pYRI-3 B. abortus 2308 chromosomal DNA containing the complete 
wadB gene with attB sites, generated by PCR and cloned into 
pDONR221 (Invitrogen) 
 
This work 
pwadB attL1-attL2 fragment of pYRI-3 cloned into the attR1-attR2 sites 
of pRH001 
 
This work 
pBBR1MCS-2  
GFP 
pBBR1MCS-2 derivative expressing the gfp-mut3 gene under 
the control of the lac promoter 
Dr. J.P. Gorvel, INSERM-CNRS, 
Marseille, France. 
 
